BriaCell Therapeutics Corp. Gains 43.12%
Tue, Jan 13, 2026 at 07:22 PM
BriaCell Therapeutics Corp. (BCTX:NASDAQ) rocketted at $10.92, representing a gain of 43.1%. On Tue, Jan 13, 2026, BCTX:NASDAQ touched a New 2-Week High of $10.92. The stock appeared on our News Catalysts scanner on Wed, Jan 07, 2026 at 10:56 AM in the 'BIOTECH' category. From Tue, Dec 30, 2025, the stock recorded 55.56% Up Days and 40.00% Green Days
About BriaCell Therapeutics Corp. (BCTX:NASDAQ)
BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 276.19%
- Beyond Air, Inc. (XAIR:NASDAQ), 150%
- TryHard Holdings Limited (THH:NASDAQ), 138.31%
- Ambitions Enterprise Management Co. L.L.C (AHMA:NASDAQ), 133.71%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 56.66%
- HUB Cyber Security Ltd. (HUBC:NASDAQ), 56.49%
- JIADE Limited (JDZG:NASDAQ), 53.63%
- iOThree Limited (IOTR:NASDAQ), 52.11%
- Decoy Therapeutics Inc Com Par $0.0001 (New) (DCOY:NASDAQ), 50.64%
- BriaCell Therapeutics Corp. (BCTX:NASDAQ), 43.12%